Vifant Overview

  • Founded
  • 2015
  • Status
  • Private
  • Latest Deal Type
  • Grant
  • Latest Deal Amount
  • $225K
Latest Deal Amount
  • Investors
  • 2

Vifant General Information


Developer of a mobile application designed to identify vision impairment in verbal, non-verbal and pre-verbal patients. The company's application uses the established principle of optico-kinetic nystagmus which is the eyes' reflexive, spontaneous response to moving patterns that does not need to be instructed or learned, enabling users to detect of vision problems early in a cost-effective way.

Contact Information

Ownership Status
Privately Held (backing)
Financing Status
Accelerator/Incubator Backed
Primary Industry
Outcome Management (Healthcare)
Other Industries
Application Software
Primary Office
  • 3401 Grays Ferry Avenue
  • Philadelphia, PA 19146
  • United States
+1 (215) 000-0000
Want detailed data on 3M+ companies?

What you see here scratches the surface

Request a free trial
Want to dig into this profile?

We’ll help you find what you need

Learn more

Vifant Valuation & Funding

Deal Type Date Amount Raised to Date Post-Val Status Stage
2. Grant 01-Jan-2018 $225K Completed Startup
1. Accelerator/Incubator 01-Sep-2015 Completed Startup
To view Vifant’s complete valuation and funding history, request access »

Vifant Executive Team (3)

Name Title Board Seat Contact Info
Beth DeSouza Chief Executive Officer
Det Ansinn Chief Technology Officer
Monte Mills Founder
To view Vifant’s complete executive team members history, request access »

Vifant Investors (2)

Investor Name Investor Type Holding Investor Since Participating Rounds Contact Info
America's Seed Fund Government 000 0000 000000 0
UPstart Accelerator/Incubator Minority 000 0000 000000 0
To view Vifant’s complete investors history, request access »